Latest in Pharmaceutical

Early phase analytical strategy for biosimilars in a shifting regulatory landscape

As FDA and EMA guidance continues to reinforce analytical comparability as the foundation of biosimilar development, investing in comprehensive early-stage characterisation is becoming essential to reduce uncertainty and improve development outcomes, says Dr Andrew J. Reason, CEO at BioPharmaSpec

Find out more
Early phase analytical strategy for biosimilars in a shifting regulatory landscape

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

The new AI-powered platform combines autonomous digital workers, interoperable healthcare data and compliance tools to help pharmaceutical manufacturers, medical device...
See more
Plan your marketing strategy with Manufacturing Chemist

Plan your marketing strategy with Manufacturing Chemist

Discover upcoming special reports, themed features and commercial opportunities to help you connect with pharmaceutical manufacturing decision-makers throughout the year
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline risk in at-risk older adults during a three-year period
Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

The agreement will expand Teva’s biosimilars pipeline, with the company securing exclusive commercialisation rights for Polpharma Biologics’ proposed ocrelizumab biosimilar across key global markets
Sanofi offers EU commitments for flu vaccine disparagement claims

Sanofi offers EU commitments for flu vaccine disparagement claims

Sanofi has proposed remedies to EU antitrust regulators after allegations it disparaged rival CSL Seqirus's Fluad vaccine in Germany and France since 2024
IMCD opens new Pharmaceutical Technical Centre in New Jersey

IMCD opens new Pharmaceutical Technical Centre in New Jersey

IMCD has launched a new Pharmaceutical Technical Centre in Allendale, New Jersey, offering advanced formulation support for solid, semi-solid and liquid dosage forms, alongside a co-located Food & Nutrition US Technical Hub
MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

MSD partners with Abu Dhabi to explore regional pharma logistics hub in HELM Cluster

The collaboration would strengthen supply chain resilience and accelerate access to innovative therapies across the region, subject to approvals, positioning Abu Dhabi as a secure distribution gateway for global pharma
You need to be a subscriber to read this article.
Click here to find out more.
Neuland Laboratories announces new $20m process development lab in Hyderabad

Neuland Laboratories announces new $20m process development lab in Hyderabad

The new facility will be fully operational by October 2026 and will give clients earlier manufacturability insight when looking to scale up, through the incorporation of non-GMP kilo labs as well as AI-driven route scouting, parallel synthesis and ELNs
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Pharmaceutical

FDA approves Utebzi, first oral carbapenem antibiotic, for complicated UTIs

FDA approves Utebzi, first oral carbapenem antibiotic, for complicated UTIs

GSK and Spero Therapeutics' tebipenem pivoxil matches IV imipenem-cilastatin in Phase III trials, offering an outpatient alternative for resistant infections that cost the US healthcare system more than $6bn annually
Why Pharma's supply chain technology investments are falling short of resilience

Why Pharma's supply chain technology investments are falling short of resilience

The pharmaceutical industry has spent the best part of six years reassessing its supply chain
Grifols launches FESILTY fibrinogen concentrate in US for congenital fibrinogen deficiency

Grifols launches FESILTY fibrinogen concentrate in US for congenital fibrinogen deficiency

The FDA-approved plasma-derived concentrate enables rapid, predictable fibrinogen restoration in paediatric and adult patients — reconstituting in three minutes and offering a purified alternative to cryoprecipitate and fresh frozen plasma
ZoBio launches integrated DEL hit discovery service for challenging drug targets

ZoBio launches integrated DEL hit discovery service for challenging drug targets

The new library-agnostic platform combines DEL screening with X-ray crystallography, quantitative biophysics and off-DNA validation, delivering structurally characterised, progressible starting points beyond conventional hit identification
Axplora consolidates UDCA manufacturing at FDA-approved Vizag site using green chemistry process

Axplora consolidates UDCA manufacturing at FDA-approved Vizag site using green chemistry process

The transition from Gropello Cairoli to India frees Farmabios to focus on HPAPI and steroid leadership, while Vizag's enzymatic synthesis route and backwards-integrated bile sourcing strengthen global API supply resilience
MHRA approves first oral semaglutide tablet for weight loss in the UK

MHRA approves first oral semaglutide tablet for weight loss in the UK

Novo Nordisk's Wegovy tablet becomes the UK's first GLP-1 receptor agonist in oral form for obesity treatment — a significant shift in delivery format as the drug awaits NICE evaluation for NHS access
The IND advantage: why early derisking is a strategic imperative for complex biologics

The IND advantage: why early derisking is a strategic imperative for complex biologics

As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating programmes that reach IND on time from those that don't, says Yvette Stallwood, Head of Early Development Services at Lonza
CellCarta and Leica Biosystems expand companion disgnostic development model partnership

CellCarta and Leica Biosystems expand companion disgnostic development model partnership

Building on a successful CDx joint development model in China, the pair will aim to bring the end-to-end development framework to global customers to help their customers streamline the path to global CDx commercialisation
ystral opens ATEX-compliant trial centre in Germany to expand customer process development capacity

ystral opens ATEX-compliant trial centre in Germany to expand customer process development capacity

The new facility, based in Ballrechten-Dottingen, will be able to handle flammable and explosive media testing across pharma, coatings and food applications, with remote livestream access and in-house particle size and viscosity analysis
CelLBxHealth and AstraZeneca sign Master Services Agreement

CelLBxHealth and AstraZeneca sign Master Services Agreement

The new contract establishes CelLBxHealth as a qualified service provider to AstraZeneca, allowing it to support drug discovery and development through CTC-powered analytics of clinical trial samples with its Parsortix platform
Nestlé Health Science and IdB partner to bring VOWST to Europe

Nestlé Health Science and IdB partner to bring VOWST to Europe

Nestlé Health Science and IdB Holding have signed a licensing agreement to seek EMA approval for VOWST, the only FDA-approved oral live biotherapeutic for recurrent C. diff prevention

Sponsor content

Formulation freedom in clinical development: Why Fill2Weight matters

Formulation freedom in clinical development: Why Fill2Weight matters

As drug discovery accelerates, especially for poorly soluble small‑molecule compounds, formulation teams increasingly modify particle size, morphology and structure to...
Pouching solutions for sterile and moisture-sensitive devices

Pouching solutions for sterile and moisture-sensitive devices

Sterile pouch loading and sealing is far more complex than a conventional packaging operation: When the pouch itself becomes the primary sterile barrier (and the product...
How a manufacturer tripled granulation line productivity

How a manufacturer tripled granulation line productivity

A global manufacturer exporting to US markets was facing a 20% rejection rate for Sucralfate Tablets, leading to order non-fulfilment penalties
Measurement uncertainty explained – Why it matters more than you think

Measurement uncertainty explained – Why it matters more than you think

In regulated environments, where decisions often depend on whether a result passes or fails a defined limit, understanding measurement uncertainty becomes critical
What is ISO/IEC 17025 and why it matters for calibration

What is ISO/IEC 17025 and why it matters for calibration

As regulatory expectations continue to increase, particularly around data integrity and traceability, the question becomes less about collecting data, and more about...
NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

NSF Pharma Biotech Conference Q&A highlights priorities for contamination control, quality culture and workforce development

The discussion underscored the growing importance of aligning employee behaviours with compliance objectives, while also addressing the industry’s ongoing challenges...
Maximising product recovery with a GFD filter dryer removable basket

Maximising product recovery with a GFD filter dryer removable basket

Product value is often inversely proportional to volume in pharmaceutical R&D and kilo-lab production. When synthesising a few hundred grams of a novel drug candidate,...
How pressure and vacuum filtration in ANFDs improves yield

How pressure and vacuum filtration in ANFDs improves yield

During solid-liquid separation in industries such as pharmaceuticals and fine chemicals, both process efficiency and product quality are critical requirements. Effective...
SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge

SCHOTT Pharma expands ready-to-use portfolio with sterile 1.5 ml cartridge

The 1.5 ml cartridge is the smallest format in SCHOTT Pharma’s sterile cartriQ portfolio, streamlining the pharmaceutical filling process for a wide range of drugs. It...
How to avoid the top 5 pharma data integrity failures

How to avoid the top 5 pharma data integrity failures

Regulatory bodies like the MHRA and FDA expect every piece of environmental data to be accurate, complete, and traceable, from the moment it’s captured to the time...
Choosing a modular filter dryer with flexible vessel materials

Choosing a modular filter dryer with flexible vessel materials

Design teams in pharmaceutical and chemical research face mounting pressure to move faster without compromising precision or safety. The Agitated Nutsche Filter Dryer...
How particle size classification drives product consistency and quality in complex injectables

How particle size classification drives product consistency and quality in complex injectables

Pharmaceutical pipelines have shifted decisively toward complex drug delivery systems like long-acting injectables (LAIs), but this innovation poses new quality challenges

Featured companies

3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support... We create clean environments to enable scientists, researchers, technicians and engineers to work safely, effectively and sustainably.
See more